Study of Blood Samples in Patients With Breast Cancer
Conditions
Breast Cancer
Conditions: official terms
Breast Neoplasms
Conditions: Keywords
recurrent breast cancer, stage IA breast cancer, stage IB breast cancer, stage II breast cancer, stage IIIA breast cancer, stage IIIB breast cancer, stage IIIC breast cancer, stage IV breast cancer
Study Type
Observational
Study Phase
N/A
Study Design
N/A
Intervention
Name: laboratory biomarker analysis
Type: Other
Overall Status
Recruiting
Summary
RATIONALE: Studying the genes expressed in samples of blood from patients with cancer may help doctors identify biomarkers related to cancer. It may also help doctors predict how patients will respond to chemotherapy.

PURPOSE: This clinical trial is studying blood samples in patients with breast cancer.
Detailed Description
OBJECTIVES:

- Identify constitutional gene variants associated with a change in response.

OUTLINE: Blood samples are collected periodically for analysis of genetic factors.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Female
Criteria: DISEASE CHARACTERISTICS:

- Histologically confirmed breast carcinoma

- Received first-line chemotherapy (in neoadjuvant or metastatic setting) comprising anthracyclines and/or taxanes, including for a second primary cancer

- Patient agrees to conservative surgery

- Hormone receptor status not specified

PATIENT CHARACTERISTICS:

- Menopausal status not specified

- No contraindication for chemotherapy comprising anthracyclines and/or taxanes

PRIOR CONCURRENT THERAPY:

- See Disease Characteristics

- No prior adjuvant therapy
Location
Centre Oscar Lambret
Lille, France
Status: Recruiting
Contact: Jacques Bonneterre, MD, PhD - 33-3-20-29-5959 - j.bonneterre@o-lambret.fr
Start Date
November 2007
Sponsors
Centre Oscar Lambret
Source
National Cancer Institute (NCI)
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page